Bioverativ Therapeutics Inc.
Bioverativ Therapeutics Inc., a leading biotechnology company headquartered in the United States, focuses on developing innovative therapies for patients with rare blood disorders. Founded in 2017, Bioverativ has quickly established itself in the biopharmaceutical industry, particularly in the areas of haemophilia and other blood-related conditions.
The company’s core products, including its advanced therapies for haemophilia A and B, are distinguished by their unique mechanisms of action and commitment to improving patient outcomes. Bioverativ's dedication to research and development has positioned it as a key player in the market, achieving significant milestones in clinical trials and product launches. With a strong emphasis on patient-centric solutions, Bioverativ continues to make strides in transforming the treatment landscape for individuals with bleeding disorders.
+62 vs industry average
Bioverativ Therapeutics Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bioverativ Therapeutics Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Bioverativ Therapeutics Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bioverativ Therapeutics Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Bioverativ Therapeutics Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project